Dernières informations, décryptages, analyses et témoignages dans notre dossier spécial consacré à la guerre au Proche-Orient ...

To top things off, the building he owns in Seoul is called Faker Tower, so none of the building’s tenants have any doubt as to who their landlord is. We live in a world where paying rent to the GOAT ...

Au sein du ministère de l’Intérieur, le SSMSI est le service statistique en charge de la sécurité intérieure, placé sous l’autorité conjointe du directeur général de la police nationale et du ...

Roivant, the source of Roche’s TL1A prospect, reported a 21% delta compared to placebo after 12 weeks. Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted rate of endoscopic ...

Mais ce scrutin est surtout fortement marqué par la poussée de l’extrême droite. Le parti Alternative pour l’Allemagne (AfD) est arrivé en deuxième place avec 19,5 % des voix, toujours ...

SSC High Rise, the local construction company building the tower's concrete superstructure, pled guilty to second-degree manslaughter before shuttering its doors for business in March of 2018.

À moins que vous n'habitiez sous une roche, vous avez assurément entendu cette rhétorique à plusieurs reprises venant de Kent Hughes, Jeff Gorton, et le reste de la direction des Canadiens de ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

But those days had settled down. Or so we thought. This week, Roche made it feel like 2022 again. Just days before the AGBT meeting kicks off in Marco Island, FL, the company hosted a much ...

Roche’s innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

The Nova Scotia government has announced it has finalized an agreement to construct a $7.4-billion 14-storey tower at a Halifax hospital site that will be ready for patients by 2031. Under a deal ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. At Novartis, CEO Vas Narasimhan’s overall 2024 pay ...